Scott Goldstein – Employee Spotlight
Meet Scott Goldstein – Vice President of Strategic Partnerships, Drug Product Manufacturing at Argonaut Can you describe your role at Argonaut? No two days are
Category: Combination Product
Broad Institute Selects Argonaut to Manufacture Compound for Potential Clinical Trial
Argonaut Manufacturing Services Selected to Manufacture siRNA Medicines for Potential Prion Disease Trial Argonaut to support manufacturing needs of an siRNA therapeutic for a potential
Sterile Fill-finish Capabilities Update – Summary of Outsourced Pharma Webinar
Scott Goldstein, the Vice President of Strategic Partnerships at Argonaut Manufacturing Services, caught up with Perry Rearick at Outsourced Pharma to present a webinar covering
Stacy Sutton – Employee Spotlight
Meet Stacy Sutton – SVP/General Manager, Life Science Division at Argonaut What’s a day in the life of a General Manager at Argonaut? “As General
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner
Long-standing partnership strengthens as both companies target growth in IVD sector Carlsbad, CA, Jan 28, 2025 — Argonaut Manufacturing Services (“Argonaut”), a leading contract
Risk Evaluation in Pharmaceutical Fill/Finish Sourcing
Tips for Risk Evaluation in Pharmaceutical Fill/Finish Sourcing In this post we focus on the critical decision pharmaceutical companies face regarding their fill/finish needs: whether
Overcoming Challenges in Combination Product Manufacturing
Addressing novel modalities create the largest challenges in combination product manufacturing. Challenges in combination product manufacturing must overcome what has traditionally been two different manufacturing
Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies
Biopharma gains a seamless transition from drug discovery through drug product manufacturing San Diego, CA, June 20, 2024 – Abzena, the leading end-to-end integrated contract
Five Advantages of Dual-Sourcing in Pharmaceutical Fill/Finish – Understanding the Imperative
How resilient is your manufacturing strategy in the face of potential disruptions to the pharmaceutical supply chain? As we navigate the complex landscape of aseptic
Expanding in Combination Product and Drug Fill/Finish – Starting 2024 Strong
Why Your Biotech Contract Manufacturer is Expanding in Combination Product and Drug-Fill/Finish in 2024 Letter to Our Colleagues, from Founder/CEO Wayne Woodard, Argonaut Manufacturing Services